59 studies found for:    Open Studies | "Cholangiocarcinoma"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Cholangiocarcinoma"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Combined Biological Treatment and Chemotherapy for Patients With Inoperable Cholangiocarcinoma
Condition: Cholangiocarcinoma
Interventions: Drug: Gemcitabine, Oxaliplatin, Capecitabine,;   Drug: Panitumumab, Gemcitabine, Oxaliplatin, Capecitabine
2 Recruiting Comparison of Endoscopic Radiofrequency Ablation Versus Photodynamic Therapy for Inoperable Cholangiocarcinoma
Condition: Cholangiocarcinoma
Interventions: Procedure: Self expanding metallic stent (SEMS);   Procedure: Endoscopic radiofrequency ablation (ERFA);   Procedure: Photodynamic therapy (PDT)
3 Recruiting The Role of Gadoxetate (Eovist) Enhanced CT in Evaluating Cholangiocarcinoma
Condition: Cholangiocarcinoma
Intervention: Radiation: CT scan
4 Unknown  Preoperative Biliary Drainage for Resectable Hilar Cholangiocarcinoma
Conditions: Cholangiocarcinoma;   Drainage;   Surgery
Intervention: Procedure: Preoperative biliary drainage
5 Unknown  Study of RAD001 in Advanced Cholangiocarcinoma: RADiChol
Condition: Cholangiocarcinoma
Intervention: Drug: RAD001
6 Recruiting S-1 and Photodynamic Therapy in Cholangiocarcinoma
Condition: Cholangiocarcinoma
Interventions: Drug: S-1 Chemotherapy;   Procedure: Photodynamic therapy;   Procedure: Systemic chemotherapy except S-1
7 Recruiting Photodynamic Therapy (PDT) for Palliation of Cholangiocarcinoma
Conditions: Cholangiocarcinoma;   Biliary Stricture;   Biliary Obstruction;   Bile Duct Cancer
Intervention: Procedure: Photodynamic Therapy
8 Recruiting Combination Chemotherapy Plus Panitumumab or Bevacizumab for Inoperable Cholangiocarcinoma Without KRAS Mutations
Condition: Cholangiocarcinoma
Interventions: Drug: Gemcitabine;   Drug: Oxaliplatin;   Drug: Capecitabine;   Drug: Panitumumab;   Drug: Bevacizumab
9 Recruiting Registry Study of Neoadjuvant Chemoradiation & Transplant for Cholangiocarcinoma Patients
Condition: Cholangiocarcinoma
Intervention: Other: Observation data collection study.
10 Recruiting A Study of Sunitinib in Patients With Advanced Cholangiocarcinoma
Condition: Advanced and Unresectable Cholangiocarcinoma
Intervention: Drug: Sunitinib
11 Unknown  Calcitriol in Advanced Intrahepatic Cholangiocarcinoma
Condition: Advanced Intrahepatic Cholangiocarcinoma
Intervention: Drug: Calcitriol
12 Unknown  Quality of Life in Patients With Unresectable Hilar Cholangiocarcinoma on Palliative Metallic Stent Versus Plastic Stent
Condition: Unresectable Hilar Cholangiocarcinoma
Intervention: Device: biliary stent
13 Recruiting 6,8-Bis(Benzylthio)Octanoic Acid in Treating Patients With Advanced or Metastatic Bile Duct Cancer That Cannot Be Removed By Surgery
Conditions: Adult Primary Cholangiocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Cholangiocarcinoma of the Extrahepatic Bile Duct;   Cholangiocarcinoma of the Gallbladder;   Localized Unresectable Adult Primary Liver Cancer;   Metastatic Extrahepatic Bile Duct Cancer;   Recurrent Adult Primary Liver Cancer;   Recurrent Extrahepatic Bile Duct Cancer;   Unresectable Extrahepatic Bile Duct Cancer
Intervention: Drug: 6,8-bis(benzylthio)octanoic acid
14 Recruiting Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies
Conditions: Acinar Cell Adenocarcinoma of the Pancreas;   Adenocarcinoma of the Gallbladder;   Adenocarcinoma of Unknown Primary;   Adult Primary Cholangiocellular Carcinoma;   Advanced Adult Primary Liver Cancer;   Cholangiocarcinoma of the Extrahepatic Bile Duct;   Cholangiocarcinoma of the Gallbladder;   Diffuse Adenocarcinoma of the Stomach;   Duct Cell Adenocarcinoma of the Pancreas;   Intestinal Adenocarcinoma of the Stomach;   Localized Unresectable Adult Primary Liver Cancer;   Metastatic Carcinoma of Unknown Primary;   Metastatic Extrahepatic Bile Duct Cancer;   Mixed Adenocarcinoma of the Stomach;   Mucinous Adenocarcinoma of the Colon;   Mucinous Adenocarcinoma of the Rectum;   Newly Diagnosed Carcinoma of Unknown Primary;   Signet Ring Adenocarcinoma of the Colon;   Signet Ring Adenocarcinoma of the Rectum;   Stage III Pancreatic Cancer;   Stage IIIA Colon Cancer;   Stage IIIA Gallbladder Cancer;   Stage IIIA Gastric Cancer;   Stage IIIA Rectal Cancer;   Stage IIIB Colon Cancer;   Stage IIIB Gallbladder Cancer;   Stage IIIB Gastric Cancer;   Stage IIIB Rectal Cancer;   Stage IIIC Colon Cancer;   Stage IIIC Gastric Cancer;   Stage IIIC Rectal Cancer;   Stage IV Gastric Cancer;   Stage IV Pancreatic Cancer;   Stage IVA Colon Cancer;   Stage IVA Gallbladder Cancer;   Stage IVA Rectal Cancer;   Stage IVB Colon Cancer;   Stage IVB Gallbladder Cancer;   Stage IVB Rectal Cancer;   Unresectable Extrahepatic Bile Duct Cancer
Interventions: Drug: oxaliplatin;   Drug: irinotecan hydrochloride;   Drug: leucovorin calcium;   Drug: fluorouracil;   Other: laboratory biomarker analysis
15 Recruiting Optimization of Health Expenditure in Liver Surgery
Conditions: Hepatocellular Carcinoma;   Hilar Cholangiocarcinoma;   Intra Hepatic Cholangiocarcinoma;   Liver Metastasis
Intervention: Procedure: liver surgery
16 Recruiting Hepatic Arterial Infusion in Treating Patients With Locally Advanced, Non-Metastatic Cholangiocarcinoma
Conditions: Cholangiocarcinoma;   Liver Neoplasms
Interventions: Drug: floxuridine, dexamethasone;   Drug: floxuridine, dexamethasone, gemcitabine hydrochloride;   Drug: floxuridine, dexamethasone, gemcitabine hydrochloride, oxaliplatin
17 Recruiting Study Of Intrahepatic Arterial Injection of 90-Y Glass Microspheres for Cholangiocarcinoma
Condition: Cholangiocarcinoma
Intervention: Device: TheraSphere® Yttrium-90 (Y-90) Microspheres
18 Recruiting Intra-hepatic Chemotherapy in Patient With Non-resectable Liver Metastases From Cholangiocarcinoma
Condition: Cholangiocarcinoma
Interventions: Drug: Oxaliplatin, capecitabine, gemcitabine, cetuximab;   Drug: Oxaliplatin, capecitabine, gemcitabine cetuximab
19 Recruiting A Study of Gemcitabine as an Adjuvant Treatment for Cholangiocarcinoma After Surgical Resection
Condition: Cholangiocarcinoma
Intervention: Drug: Gemcitabine
20 Recruiting Stereotactic Body Radiotherapy for Hepatocellular Carcinoma, and Intrahepatic Cholangiocarcinoma
Conditions: Carcinoma, Hepatocellular;   Intrahepatic Cholangiocarcinoma
Intervention: Radiation: Stereotactic radiation

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years